Stay updated on Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page.

Latest updates to the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page
- Check2 days agoChange DetectedNew navigation and guidance sections were added to the study details page (How to Read a Study Record, Common Questions, How to Join a Study), and a recruitment status indicator 'No longer looking for participants' was introduced. The label formatting for Intervention/Treatment was adjusted and the old heading 'Intervention / Treatment' as well as the older revision tag were removed.SummaryDifference0.4%

- Check9 days agoChange DetectedStudy record metadata was updated to revision v3.5.5, replacing the previous v3.5.4 tag. This reflects a minor update to the page's revision history without changing the study content.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a minor internal update to the study page rather than changes to study data.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page’s displayed version/revision indicator has been incremented from “v3.5.2” to “v3.5.3,” reflecting a minor site update without changing the underlying clinical trial content.SummaryDifference0.1%

- Check59 days agoChange DetectedWebsite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check88 days agoChange DetectedAdded Hepatocellular carcinoma as a disease term and a link to the Genetic and Rare Diseases Information Center; updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

Stay in the know with updates to Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page.